Bear Stearns has Bausch & Lomb at peer perform

Bausch & Lomb Inc. was rated at peer perform by Bear Stearns analyst Milton Hsu after the company's cataract business is doing better than the analyst's expectations. One of the key new cataract product launches may be Bausch & Lomb's new phaco system, Stellaris, in the first half of 2007. However, the company's Pharma and Solutions businesses will likely see continued pressure from the MoistureLoc recall, with a next-generation solutions product at least two years away. Shares of the Rochester, N.Y., eye health products company were down 11 cents, or 0.22%, at $49.39. (NYSE: BOL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.